Glucosamine Pharma Nord may be available in the countries listed below.
Glucosamine is reported as an ingredient of Glucosamine Pharma Nord in the following countries:
Glucosamine sulfate (a derivative of Glucosamine) is reported as an ingredient of Glucosamine Pharma Nord in the following countries:
International Drug Name Search
Isosorbidemononitraat may be available in the countries listed below.
Isosorbide Mononitrate is reported as an ingredient of Isosorbidemononitraat in the following countries:
International Drug Name Search
Normolaxil may be available in the countries listed below.
Lactitol is reported as an ingredient of Normolaxil in the following countries:
Lactitol monohydrate (a derivative of Lactitol) is reported as an ingredient of Normolaxil in the following countries:
International Drug Name Search
Apo-Metformin may be available in the countries listed below.
Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Apo-Metformin in the following countries:
International Drug Name Search
Tolbutamide Actavis may be available in the countries listed below.
Tolbutamide is reported as an ingredient of Tolbutamide Actavis in the following countries:
International Drug Name Search
Ticlopidine Arrow may be available in the countries listed below.
Ticlopidine hydrochloride (a derivative of Ticlopidine) is reported as an ingredient of Ticlopidine Arrow in the following countries:
International Drug Name Search
Clomazol may be available in the countries listed below.
Clotrimazole is reported as an ingredient of Clomazol in the following countries:
International Drug Name Search
Zutex may be available in the countries listed below.
Ceftriaxone is reported as an ingredient of Zutex in the following countries:
International Drug Name Search
Fenogal Lidose may be available in the countries listed below.
Fenofibrate is reported as an ingredient of Fenogal Lidose in the following countries:
International Drug Name Search
Sertralina Vir may be available in the countries listed below.
Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Sertralina Vir in the following countries:
International Drug Name Search
Virorrever may be available in the countries listed below.
Efavirenz is reported as an ingredient of Virorrever in the following countries:
International Drug Name Search
Chloramphecort may be available in the countries listed below.
Chloramphenicol is reported as an ingredient of Chloramphecort in the following countries:
Hydrocortisone is reported as an ingredient of Chloramphecort in the following countries:
International Drug Name Search
Manicol may be available in the countries listed below.
Mannitol is reported as an ingredient of Manicol in the following countries:
International Drug Name Search
Declovir may be available in the countries listed below.
Aciclovir is reported as an ingredient of Declovir in the following countries:
International Drug Name Search
Tetrilin may be available in the countries listed below.
Tetryzoline hydrochloride (a derivative of Tetryzoline) is reported as an ingredient of Tetrilin in the following countries:
International Drug Name Search
Ocupred may be available in the countries listed below.
Prednisolone 21-acetate (a derivative of Prednisolone) is reported as an ingredient of Ocupred in the following countries:
International Drug Name Search
Rinoflumil may be available in the countries listed below.
Acetylcysteine is reported as an ingredient of Rinoflumil in the following countries:
Tuaminoheptane sulfate (a derivative of Tuaminoheptane) is reported as an ingredient of Rinoflumil in the following countries:
International Drug Name Search
Roxihexal may be available in the countries listed below.
Roxithromycin is reported as an ingredient of Roxihexal in the following countries:
International Drug Name Search
Voltarenactigo may be available in the countries listed below.
Diclofenac diethylamine (a derivative of Diclofenac) is reported as an ingredient of Voltarenactigo in the following countries:
International Drug Name Search
In the US, Somatropin (somatropin systemic) is a member of the drug class growth hormones and is used to treat Adult Human Growth Hormone Deficiency, AIDS Related Wasting, Burns - Nitrogen Retention, Cachexia, Growth Retardation - Chronic Renal Failure, Hypopituitarism, Idiopathic Short Stature, Noonan's Syndrome, Pediatric Growth Hormone Deficiency, Short Bowel Syndrome, Short Stature for Age and Turner's Syndrome.
US matches:
Somatropin (BAN, JAN, USAN) is also known as Somatropine (Rec.INN)
International Drug Name Search
Glossary
| BAN | British Approved Name |
| JAN | Japanese Accepted Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
See also: Generic Lupron Depot-PED
Lupron Depot is a brand name of leuprolide, approved by the FDA in the following formulation(s):
No. There is currently no therapeutically equivalent version of Lupron Depot available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Lupron Depot. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.
Xylocain mit Adrenalin may be available in the countries listed below.
Epinephrine bitartrate (a derivative of Epinephrine) is reported as an ingredient of Xylocain mit Adrenalin in the following countries:
Lidocaine hydrochloride (a derivative of Lidocaine) is reported as an ingredient of Xylocain mit Adrenalin in the following countries:
Lidocaine hydrochloride monohydrate (a derivative of Lidocaine) is reported as an ingredient of Xylocain mit Adrenalin in the following countries:
International Drug Name Search
Flumil may be available in the countries listed below.
Acetylcysteine is reported as an ingredient of Flumil in the following countries:
Fluconazole is reported as an ingredient of Flumil in the following countries:
International Drug Name Search
Parofen may be available in the countries listed below.
Ibuprofen is reported as an ingredient of Parofen in the following countries:
International Drug Name Search
Mylepsinum may be available in the countries listed below.
Primidone is reported as an ingredient of Mylepsinum in the following countries:
International Drug Name Search
Simva Basics may be available in the countries listed below.
Simvastatin is reported as an ingredient of Simva Basics in the following countries:
International Drug Name Search
Roxithromycin Stada may be available in the countries listed below.
Roxithromycin is reported as an ingredient of Roxithromycin Stada in the following countries:
International Drug Name Search
Nimesulida Ratiopharm may be available in the countries listed below.
Nimesulide is reported as an ingredient of Nimesulida Ratiopharm in the following countries:
International Drug Name Search
Dolonet may be available in the countries listed below.
Ibuprofen is reported as an ingredient of Dolonet in the following countries:
International Drug Name Search
Ange may be available in the countries listed below.
Ethinylestradiol is reported as an ingredient of Ange in the following countries:
Levonorgestrel is reported as an ingredient of Ange in the following countries:
International Drug Name Search
Raloxifène may be available in the countries listed below.
Raloxifène (DCF) is known as Raloxifene in the US.
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
Fabolergic may be available in the countries listed below.
Diphenhydramine hydrochloride (a derivative of Diphenhydramine) is reported as an ingredient of Fabolergic in the following countries:
International Drug Name Search
Euglitol may be available in the countries listed below.
Miglitol is reported as an ingredient of Euglitol in the following countries:
International Drug Name Search
Piperazyl may be available in the countries listed below.
Piperazine citrate (a derivative of Piperazine) is reported as an ingredient of Piperazyl in the following countries:
International Drug Name Search
GEL-PHAN may be available in the countries listed below.
Gelatin is reported as an ingredient of GEL-PHAN in the following countries:
International Drug Name Search
Ranitidine Etos may be available in the countries listed below.
Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Ranitidine Etos in the following countries:
International Drug Name Search
Prop.INN
0000053-46-3
C21-H26-Br-N-O3
420
Antispasmodic agent
Parasympatholytic agent
Gastric acid secretion inhibitor
Ethanaminium, N,N-diethyl-N-methyl-2-[(9H-xanthen-9-ylcarbonyl)oxy]-, bromide
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Prop.INN | Proposed International Nonproprietary Name (World Health Organization) |
Thioguanin-GSK may be available in the countries listed below.
Tioguanine is reported as an ingredient of Thioguanin-GSK in the following countries:
International Drug Name Search
Ultrazole may be available in the countries listed below.
Lansoprazole is reported as an ingredient of Ultrazole in the following countries:
International Drug Name Search
Chian may be available in the countries listed below.
Glucosamine sulfate (a derivative of Glucosamine) is reported as an ingredient of Chian in the following countries:
International Drug Name Search
Miocor may be available in the countries listed below.
Amiodarone hydrochloride (a derivative of Amiodarone) is reported as an ingredient of Miocor in the following countries:
Levocarnitine is reported as an ingredient of Miocor in the following countries:
International Drug Name Search
clindamycine Fresenius may be available in the countries listed below.
Clindamycin dihydrogen phosphate (a derivative of Clindamycin) is reported as an ingredient of clindamycine Fresenius in the following countries:
International Drug Name Search
Sulfaquinoxaline Natrium may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Sulfaquinoxaline sodium salt (a derivative of Sulfaquinoxaline) is reported as an ingredient of Sulfaquinoxaline Natrium in the following countries:
International Drug Name Search
Foot Rot Aerosol may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Cetrimide is reported as an ingredient of Foot Rot Aerosol in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
Sulfadimidine is reported as an ingredient of Seeco Tylan in the following countries:
Tylosin phosphate (a derivative of Tylosin) is reported as an ingredient of Seeco Tylan in the following countries:
International Drug Name Search
The following drugs and medications are in some way related to, or used in the treatment of Dermal Necrosis, Treatment. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Medical Encyclopedia:
Atropin EDO may be available in the countries listed below.
Atropine sulfate (a derivative of Atropine) is reported as an ingredient of Atropin EDO in the following countries:
International Drug Name Search
Palitenox may be available in the countries listed below.
Tenoxicam is reported as an ingredient of Palitenox in the following countries:
International Drug Name Search
Amoxivet may be available in the countries listed below.
Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxivet in the following countries:
International Drug Name Search
Indapamide Teva may be available in the countries listed below.
Indapamide is reported as an ingredient of Indapamide Teva in the following countries:
International Drug Name Search
Alkosalen may be available in the countries listed below.
Flumetasone 21-pivalate (a derivative of Flumetasone) is reported as an ingredient of Alkosalen in the following countries:
Salicylic Acid is reported as an ingredient of Alkosalen in the following countries:
International Drug Name Search
Magnerot may be available in the countries listed below.
Magnesium Gluconate dihydrate (a derivative of Magnesium Gluconate) is reported as an ingredient of Magnerot in the following countries:
Magnesium Hydrogen Aspartate dihydrate (a derivative of Magnesium Hydrogen Aspartate) is reported as an ingredient of Magnerot in the following countries:
Magnesium Hydrogen Aspartate tetrahydrate (a derivative of Magnesium Hydrogen Aspartate) is reported as an ingredient of Magnerot in the following countries:
Magnesium Orotate is reported as an ingredient of Magnerot in the following countries:
Magnesium Orotate dihydrate (a derivative of Magnesium Orotate) is reported as an ingredient of Magnerot in the following countries:
International Drug Name Search
Lactulosa Farmindustria may be available in the countries listed below.
Lactulose is reported as an ingredient of Lactulosa Farmindustria in the following countries:
International Drug Name Search
Trimetazide may be available in the countries listed below.
Trimetazidine is reported as an ingredient of Trimetazide in the following countries:
International Drug Name Search
Enalapril-saar may be available in the countries listed below.
Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Enalapril-saar in the following countries:
International Drug Name Search
Beclometasona Merck may be available in the countries listed below.
Beclometasone 17α,21-dipropionate (a derivative of Beclometasone) is reported as an ingredient of Beclometasona Merck in the following countries:
International Drug Name Search
Montélukast may be available in the countries listed below.
Montélukast (DCF) is known as Montelukast in the US.
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
Trinitrosan may be available in the countries listed below.
Nitroglycerin is reported as an ingredient of Trinitrosan in the following countries:
International Drug Name Search
In the US, Portia (ethinyl estradiol/levonorgestrel systemic) is a member of the drug class contraceptives and is used to treat Abnormal Uterine Bleeding, Birth Control, Endometriosis, Gonadotropin Inhibition, Ovarian Cysts and Polycystic Ovary Syndrome.
US matches:
Ethinylestradiol is reported as an ingredient of Portia in the following countries:
Levonorgestrel is reported as an ingredient of Portia in the following countries:
International Drug Name Search
Meptin Mini may be available in the countries listed below.
Procaterol hydrochloride (a derivative of Procaterol) is reported as an ingredient of Meptin Mini in the following countries:
International Drug Name Search
Flavuril may be available in the countries listed below.
Ipratropium Bromide is reported as an ingredient of Flavuril in the following countries:
International Drug Name Search
Servitet may be available in the countries listed below.
Tetracycline hydrochloride (a derivative of Tetracycline) is reported as an ingredient of Servitet in the following countries:
International Drug Name Search
Maprotilin-ratiopharm may be available in the countries listed below.
Maprotiline hydrochloride (a derivative of Maprotiline) is reported as an ingredient of Maprotilin-ratiopharm in the following countries:
International Drug Name Search
Papavérine Renaudin may be available in the countries listed below.
Papaverine hydrochloride (a derivative of Papaverine) is reported as an ingredient of Papavérine Renaudin in the following countries:
International Drug Name Search
Benoxygel may be available in the countries listed below.
Benzoyl Peroxide is reported as an ingredient of Benoxygel in the following countries:
International Drug Name Search
Alendronat Ratiopharm may be available in the countries listed below.
Alendronic Acid is reported as an ingredient of Alendronat Ratiopharm in the following countries:
Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Alendronat Ratiopharm in the following countries:
International Drug Name Search
iProfen may be available in the countries listed below.
Ibuprofen is reported as an ingredient of iProfen in the following countries:
International Drug Name Search
Ganvirel may be available in the countries listed below.
Lamivudine is reported as an ingredient of Ganvirel in the following countries:
International Drug Name Search
Gentreks may be available in the countries listed below.
Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Gentreks in the following countries:
International Drug Name Search
Generic Name: estrogen (Oral route, Parenteral route, Topical application route, Transdermal route)
In the U.S.
In Canada
Available Dosage Forms:
Estrogens are female hormones. They are produced by the body and are necessary for the normal sexual development of the female and for the regulation of the menstrual cycle during the childbearing years.
The ovaries begin to produce less estrogen after menopause (the change of life). This medicine is prescribed to make up for the lower amount of estrogen. Estrogens help relieve signs of menopause, such as hot flashes and unusual sweating, chills, faintness, or dizziness.
Estrogens are prescribed for several reasons:
Estrogens may also be used for other conditions as determined by your doctor.
There is no medical evidence to support the belief that the use of estrogens will keep the patient feeling young, keep the skin soft, or delay the appearance of wrinkles. Nor has it been proven that the use of estrogens during menopause will relieve emotional and nervous symptoms, unless these symptoms are caused by other menopausal symptoms, such as hot flashes or hot flushes.
Estrogens are available only with your doctor's prescription.
Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although these uses are not included in product labeling, estrogen is used in certain patients with the following medical conditions:
Tell your doctor if you have ever had any unusual or allergic reaction to medicines in this group or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Use of this medicine before puberty is not recommended. Growth of bones can be stopped early. Girls and boys may develop growth of breasts. Girls may have vaginal changes, including vaginal bleeding.
This medicine may be used to start puberty in teenagers with some types of delayed puberty.
Elderly people are especially sensitive to the effects of estrogens. This may increase the chance of side effects during treatment, especially stroke, invasive breast cancer, and memory problems.
Estrogens are not recommended for use during pregnancy or right after giving birth. Becoming pregnant or maintaining a pregnancy is not likely to occur around the time of menopause.
Certain estrogens have been shown to cause serious birth defects in humans and animals. Some daughters of women who took diethylstilbestrol (DES) during pregnancy have developed reproductive (genital) tract problems and, rarely, cancer of the vagina or cervix (opening to the uterus) when they reached childbearing age. Some sons of women who took DES during pregnancy have developed urinary-genital tract problems.
Use of this medicine is not recommended in nursing mothers. Estrogens pass into the breast milk and their possible effect on the baby is not known.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking any of these medicines, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using medicines in this class with any of the following medicines is not recommended. Your doctor may decide not to treat you with a medication in this class or change some of the other medicines you take.
Using medicines in this class with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of medicines in this class. Make sure you tell your doctor if you have any other medical problems, especially:
For all patients
For males treated for breast or prostate cancer:
This section provides information on the proper use of a number of products that contain estrogen. It may not be specific to Oesclim. Please read with care.
Take this medicine only as directed by your doctor. Do not take more of it and do not take or use it for a longer time than your doctor ordered. For patients taking any of the estrogens by mouth, try to take the medicine at the same time each day to reduce the possibility of side effects and to allow it to work better.
This medicine usually comes with patient information or directions. Read and follow the instructions in the insert carefully. Ask your doctor if you have any questions.
For patients taking any of the estrogens by mouth or by injection:
For patients using the transdermal (skin patch):
For patients using the topical emulsion (skin lotion):
If you are using the Evamist® transdermal spray:
The dose medicines in this class will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of these medicines. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
If you miss a dose of this medicine, apply it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule.
If you forget to wear or change a patch, put one on as soon as you can. If it is almost time to put on your next patch, wait until then to apply a new patch and skip the one you missed. Do not apply extra patches to make up for a missed dose.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
Ask your healthcare professional how you should dispose of any medicine you do not use.
It is very important that your doctor check your progress at regular visits to make sure this medicine does not cause unwanted effects. These visits will usually be every year, but some doctors require them more often.
In some patients using estrogens, tenderness, swelling, or bleeding of the gums may occur. Brushing and flossing your teeth carefully and regularly and massaging your gums may help prevent this. See your dentist regularly to have your teeth cleaned. Check with your medical doctor or dentist if you have any questions about how to take care of your teeth and gums, or if you notice any tenderness, swelling, or bleeding of your gums.
Although the incidence is low, the use of estrogens may increase you chance of getting cancer of the breast, ovaries, or uterus (womb). Therefore, it is very important that you regularly check your breasts for any unusual lumps or discharge. Report any problems to your doctor. You should also have a mammogram (x-ray pictures of the breasts) done if your doctor recommends it. Because breast cancer has occurred in men taking estrogens, regular breast self-exams and exams by your doctor for any unusual lumps or discharge should be done.
If your menstrual periods have stopped, they may start again. This effect will continue for as long as the medicine is taken. However, if taking the continuous treatment (0.625 mg conjugated estrogens and 2.5 mg medroxyprogesterone once a day), monthly bleeding usually stops within 10 months.
Also, vaginal bleeding between your regular menstrual periods may occur during the first 3 months of use. Do not stop taking your medicine. Check with your doctor if bleeding continues for an unusually long time, if your period has not started within 45 days of your last period, or if you think you are pregnant.
Tell the doctor in charge that you are using this medicine before having any laboratory test because some results may be affected.
Check with your child's doctor right away if your child starts to have the following symptoms: nipple or breast swelling or tenderness in females, or enlargement of the breasts in males. Your child may have been exposed to Evamist® transdermal spray.
Do not allow your pets to lick or touch the arm where Evamist® transdermal spray was applied. Small pets may be sensitive to this medicine. Call your pet's veterinarian if your pet starts to have the following symptoms: nipple or breast enlargement, swelling of the vulva, or any signs of illness.
Women rarely have severe side effects from taking estrogens to replace estrogen. Discuss these possible effects with your doctor:
The prolonged use of estrogens has been reported to increase the risk of endometrial cancer (cancer of the lining of the uterus) in women after menopause. This risk seems to increase as the dose and the length of use increase. When estrogens are used in low doses for less than 1 year, there is less risk. The risk is also reduced if a progestin (another female hormone) is added to, or replaces part of, your estrogen dose. If the uterus has been removed by surgery (total hysterectomy), there is no risk of endometrial cancer.
Although the incidence is low, the use of estrogens may increase you chance of getting cancer of the breast. Breast cancer has been reported in men taking estrogens.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
The following side effects may be caused by blood clots, which could lead to stroke, heart attack, or death. These side effects occur rarely, and, when they do occur, they occur in men treated for cancer using high doses of estrogens.
Check with your doctor immediately if any of the following side effects occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Also, many women who are taking estrogens with a progestin (another female hormone) will start having monthly vaginal bleeding, similar to menstrual periods, again. This effect will continue for as long as the medicine is taken. However, monthly bleeding will not occur in women who have had the uterus removed by surgery (total hysterectomy).
This medicine may cause loss or thinning of the scalp hair in some people.
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
